Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

The grant, given by the European Union’s Innovative Health Initiative (EU-IHI), was awarded to Bar-Ilan University’s Dr. Sivan Spitzer, along with a team of researchers from six EU countries. The ...

US President Donald Trump has signalled plans to impose a 25% tariff on car imports, along with similar or higher levies on ...

Tariffs targeted at countries — reciprocal or regular — will likely be paid by multinational companies, dampening the outlook ...

Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...

Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...

There are many opportunities available in the international markets that never make the news in the US. The VEA and VWO ETFs ...

Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...

Political uncertainty in some of the largest European economies has diminished their growth outlook. Read more here.

Harding Loevner International Equity ADR composite fell 7.9%, gross, behind the 7.5% decline of the MSCI ACWI ex US Index. Click here to read more.

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...